Hatem C, Minello A, Bresson-Hadni S, Jooste V, Evrard P, Obert B, Lepage C, Bonithon-Kopp C, Faivre J, Monnet E, Miguet J-P, Hillon P
Réseau Bourguignon de lutte contre l'hépatite C, Faculté de médecine de Dijon, Boulevard Jeanne d'Arc, 21034 Dijon Cedex, France.
Aliment Pharmacol Ther. 2005 Apr 15;21(8):1007-15. doi: 10.1111/j.1365-2036.2005.02393.x.
In order for hepatitis C patients to receive antiviral treatment, they must reach medical care.
To assess the proportion of patients reaching medical care after hepatitis C diagnosis in a general population (1 006 171 inhabitants) in France.
Between 1994 and 1999, 1508 cases were diagnosed, of which 1251 were eligible for the study.
Two-hundred and two patients did not have any medical care; among them, 55.4% had normal alanine transferase, 58.4% had risk factors related to lifestyle and 22.8% were alcoholics. Amongst the 1049 other patients, 41.6% had a liver biopsy, 25.0% were treated. Treatment was more often carried out in males than in females (OR: 1.59; P = 0.001), and in patients under 65 than in older patients (OR: 2.22; P < 0.008). Among non-treatment reasons, alcoholism (P = 0.001), drug-addiction (P = 0.04) and escaping monitoring (P = 0.04) were more frequent in males than in females, whereas normal alanine transferase was more frequent in females than in males (P = 0.004). Amongst 278 patients with a Metavir score >A1F1, 71 (25.5%) did not undergo treatment.
In a general population, one patient in six did not receive on-going health care; a quarter of patients with a Metavir score >A1F1 did not receive any treatment. These results showed insufficient clinical management, which could compromise the effectiveness of treatment in general population.
为了让丙型肝炎患者接受抗病毒治疗,他们必须获得医疗服务。
评估法国某普通人群(1006171名居民)中丙型肝炎诊断后获得医疗服务的患者比例。
1994年至1999年期间,诊断出1508例病例,其中1251例符合研究条件。
202例患者未接受任何医疗服务;其中,55.4%的患者丙氨酸转氨酶正常,58.4%的患者有与生活方式相关的风险因素,22.8%的患者为酗酒者。在其他1049例患者中,41.6%的患者接受了肝活检,25.0%的患者接受了治疗。治疗在男性中比在女性中更常见(比值比:1.59;P = 0.001),在65岁以下患者中比在老年患者中更常见(比值比:2.22;P < 0.008)。在未治疗的原因中,酗酒(P = 0.001)、药物成瘾(P = 0.04)和逃避监测(P = 0.04)在男性中比在女性中更常见,而丙氨酸转氨酶正常在女性中比在男性中更常见(P = 0.004)。在278例Metavir评分>A1F1的患者中,71例(25.5%)未接受治疗。
在普通人群中,六分之一的患者未接受持续的医疗保健;四分之一的Metavir评分>A1F1的患者未接受任何治疗。这些结果表明临床管理不足,这可能会影响普通人群中治疗的有效性。